Business and Finance

Acquisition of US partner establishes Sanofi's plan to advance messenger RNA technology for vaccines, therapeutics

Guidance supports cross-industry collaboration for improved interoperability

Private equity companies see the sector as having a valuable ROI, according to study

Pharmacy discount card company and e-commerce specialist team up on new Rx-med procedures channel

Deal for antibody developer expected to be largest ever for scientific instrument maker

Acquisition is centered on market access and patient advocacy

Report notes that companies particularly look to vendor support for technologies such as 5G, IoT, and blockchain

Plans a multi-phase, $100 million expansion, adding biologics drug substance manufacturing capabilities

Deal allows CDMO to quickly expand its drug delivery technologies in the US

Aims to grow its digital clinical trial offerings internationally

CDMO looks to strengthen its presence in Belgium, Sweden and the Netherlands

EmerGENE to support biotechs in clinical-to-commercialization process, including distribution and logistics

Bundled $400 million acquisition provides data insights to hospitals, retail pharmacies

Acquisition by nonprofit will focus on helping strengthen drug supply chain

Arthrex to receive US rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sports medicine

Acquires Sweden-based Sentor, which specializes in security services

Collaboration with Surescripts will focus on improving patient outcomes, while providing HCPs with in-workflow enrollment

Mission is to expand its collection of mRNA vaccines beyond the Covid-19 pandemic

Merger establishes Perigon Health 360—with aim of introducing "precision digital pharmacy" model

Mourenx location will install new equipment, add hires in project as part of the France Relance recovery plan

Roche repeats at No. 1 position; AbbVie vaults five spots

Acquisition to expand presence in genomic medicine

Aims to enhance company's mRNA and viral vector capabilities

Horizon Therapeutics to purchase production facility from Irish specialty care company

How emerging life sciences organizations can create value with suppliers